Large gap with delayed quotes
Analysis date: 31.10.2025
                Global Evaluation
                
Slightly negative
        Slightly negative
The stock is classified in the slightly negative zone since 24.10.2025.
    
                Interest
                
Very weak
        Very weak
One star since 24.10.2025.
    
                Earnings Rev Trend
                
Negative
        Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 24.10.2025 at a price of 163.32.
    
                Evaluation
                
Undervalued
        Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
    
                MT Tech Trend
                
Negative
        Negative
The dividend-adjusted forty day technical trend is negative since 24.10.2025.
    
                4wk Rel Perf
                
-22.28%
        -22.28%
The four-week dividend-adjusted underperformance versus SP500 is 22.28%. 
    
                Sensibility
                
High
        High
The stock has been on the high-sensitivity level since 04.07.2025.
    
                Bear Market Factor
                
Low
        Low
On average, the stock has a tendency to minimize the drops in the index by -0.97%.
    
                Bad News Factor
                
Low
        Low
When the stock's pressure is specific, the market sanction on average is 5.15%.
    
                Mkt Cap in $bn
                
7.87
        7.87
With a market capitalization between $2 & $8bn, MOLINA HEALTHCARE is considered a mid-cap stock.
    
                G/PE Ratio
                
0.87
        0.87
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:   premium. 
    
                LT P/E
                
10.24
        10.24
The estimated PE is for the year 2027.
    
                LT Growth
                
8.87%
        8.87%
The annualized growth estimate is for the current year to 2027.
    
                Avg. Nb analysts
                
15
        15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
    
                Dividend Yield
                
0.00%
        0.00%
The company is not paying a dividend.
    
                Beta
                
-25
        -25
For 1% of index variation, the stock varies on average by -0.25%.
    
                Correlation
                
-0.08
        -0.08
Stock movements are strongly independent of index variations, with an even divergent trend.
    
                Value at Risk
                
36.75
        36.75
The value at risk is estimated at USD 36.75. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
    
                First Analysis Date
                
28.07.2004
        28.07.2004